If you need more lookups,
subscriptions start at $34 USD/month.
Susan Abushakra Location
Boston, MA, US
Susan Abushakra Work
2015 -now Chief Medical Officer @
2014 -2015 Chief Medical Officer; D5 Program Leader @ Transition Therapeutics USA
2014 -2014 Chief Medical Officer and D5 Development Leader @
2010 -2013 ELND005 Program Leader @
2006 -2010 VP Clinical Development @
2005 -2006 Therapeutic Area Head, Global Regulatory Affairs @ Wyeth Pharmaceuticals
2003 -2005 Senior Director, therapeutic area head @ Eisai Medical Research, Inc.
2003 -2005 Therepeutic Area Head, Neurology @ Eisai
2000 -2003 Clinical Research @ AstraZeneca
1992 -1997 Assistant Professor, Neurology @ Wayne State University
Susan Abushakra Education
Johns Hopkins Medical Institutions
Residency (Neurology)
1986-1992
The Johns Hopkins University School of Medicine
Residency (Research Fellowship)
1986-1992
Susan Abushakra Skills
Clinical Development
Drug Development
Pharmaceutical Industry
Clinical Research
Biotechnology
Regulatory Affairs
Clinical Trials
Life Sciences
Neurology
Oncology
Alzheimer's disease
Biologics
Biopharmaceuticals
Management
Public Speaking
Business Development
Sales
Susan Abushakra Summary
Susan Abushakra, based in Boston, MA, US, is currently a Chief Medical Officer at Alzheon, Inc.. Susan Abushakra brings experience from previous roles at Transition Therapeutics USA, Elan/Perrigo Pharmaceuticals and Allergan. Susan Abushakra holds a 1986 - 1992 Residency in Neurology @ Johns Hopkins Medical Institutions. With a robust skill set that includes Clinical Development, Drug Development, Pharmaceutical Industry, Clinical Research, Biotechnology and more. Susan Abushakra has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Susan Abushakra?
Find contact details for 700 million professionals.